Building Africa's capacity in vaccine R&D.
ThumVac represents Nothile Holdings' commitment to long-term public health and pandemic preparedness. This future-facing initiative is dedicated to establishing a robust, Africa-centric and vaccine development pipeline.
Our Vision
Our long-term goal is to integrate vaccine R&D with pilot-scale production capabilities, collaborating with continental partners to strengthen regional health security and achieve greater vaccine sovereignty.
Focus Areas:
Next-Generation Vaccines
Targeting respiratory and infectious diseases with a focus on affordability and thermostability.
Biologics R&D
Building foundational expertise in large-molecule drug development.
Partnership Development
Forging alliances with global health organizations and research institutions.
ThumVac is currently in its foundational stage. To express interest in future collaboration, please contact us.
Location: Cape Town 7925
Call 021 300 9295
Email:
Site: www.nothileholdings.co.za
FOLLOW US
